Morbidity and mortality associated with the restrictive spirometric pattern: A longitudinal study

Thorax

Volumn 65, Issue 6, 2010, Pages 499-504

  Guerra, Stefano ^a,b   Sherrill, Duane L ^a,c   Venker, Claire ^a,c   Ceccato, Christina M ^a   Halonen, Marilyn ^a,d   Martinez, Fernando D ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c UNIVERSITY OF ARIZONA   (United States)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; EPIDEMIOLOGICAL DATA; EXPIRATORY RESERVE VOLUME; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH SURVEY; HEART DISEASE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SMOKING; SPIROMETRY; STROKE; BLOOD; LUNG DISEASES; LUNG DISEASES, OBSTRUCTIVE; MIDDLE AGED; PATHOPHYSIOLOGY; RECURRENT DISEASE; SEX DIFFERENCE; UNITED STATES; VERY ELDERLY; VITAL CAPACITY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ARIZONA; ASTHMA; EPIDEMIOLOGIC METHODS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOGLOBULIN E; LUNG DISEASES; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; RECURRENCE; SEX FACTORS; SMOKING; SPIROMETRY; VITAL CAPACITY; YOUNG ADULT;

EID: 77953705906     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2009.126052     Document Type: Article

References (24)

1. Speizer FE, Fay ME, Dockery DW, et al. Chronic obstructive pulmonary disease mortality in six U.S. cities. Am Rev Respir Dis 1989;140(3 Pt 2):S49-55.
2. Hole DJ, Watt GC, Davey-Smith G, et al. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996;313:711-15;discussion 715-16. (Pubitemid 26313070)
3. Pauwels RA, Buist AS, Calverley PM, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.
4. Jemal A, Ward E, Hao Y, et al. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005;294:1255-9.
5. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
6. Ashley F, Kannel WB, Sorlie PD, et al. Pulmonary function: relation to aging, cigarette habit, and mortality. Ann Intern Med 1975;82:739-45.
7. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination. J Intern Med 2003;254:540-7.
8. Mannino DM, Buist AS, Petty TL, et al. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax 2003;58:388-93.
9. Mannino DM, Doherty DE, Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 2006;100:115-22.
10. Mannino DM, Davis KJ. Lung function decline and outcomes in an elderly population. Thorax 2006;61:472-7.
11. Ford ES, Mannino DM. Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care 2004;27:2966-70.
12. Mannino DM, Thorn D, Swensen A, et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008;32:962-9.
13. Leone N, Courbon D, Thomas F, et al. Lung function impairment and metabolic syndrome: the critical role of abdominal obesity. Am J Respir Crit Care Med 2009;179:509-16.
14. Fimognari FL, Pasqualetti P, Moro L, et al. The association between metabolic syndrome and restrictive ventilatory dysfunction in older persons. J Gerontol A Biol Sci Med Sci 2007;62:760-5. (Pubitemid 350143608)
15. Mannino DM, Holguin F, Pavlin BI, et al. Risk factors for prevalence of and mortality related to restriction on spirometry: findings from the First National Health and Nutrition Examination Survey and follow-up. Int J Tuberc Lung Dis 2005;9:613-21. (Pubitemid 40826152)
16. Johnston AK, Mannino DM, Hagan GW, et al. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax 2008;63:599-605.
17. Lebowitz MD, Knudson RJ, Burrows B. Tucson epidemiologic study of obstructive lung diseases. I: Methodology and prevalence of disease. Am J Epidemiol 1975;102:137-52.
18. Knudson RJ, Slatin RC, Lebowitz MD, et al. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am Rev Respir Dis 1976;113:587-600.
19. Knudson RJ, Lebowitz MD, Holberg CJ, et al. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-34.
20. Burrows B, Martinez FD, Halonen M, et al. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Engl J Med 1989;320:271-7. (Pubitemid 19045550)
21. Schisterman EF, Whitcomb BW. Use of the Social Security Administration Death Master File for ascertainment of mortality status. Popul Health Metr 2004;2:2.
22. Davis KB, Fisher L, Gillespie MJ, et al. A test of the National Death Index using the Coronary Artery Surgery Study (CASS). Control Clin Trials 1985;6:179-91.
23. Ray CS, Sue DY, Bray G, et al. Effects of obesity on respiratory function. Am Rev Respir Dis 1983;128:501-6.
24. Faggiano P. Abnormalities of pulmonary function in congestive heart failure. Int J Cardiol 1994;44:1-8. (Pubitemid 24110042)